{"id":"https://openalex.org/W4405041504","doi":"https://doi.org/10.1182/blood-2024-193668","title":"Azacitidine and Venetoclax with or without Donor Lymphocyte Infusion in Relapsed AML Post Allo-HSCT: A Single-Institution Retrospective Study","display_name":"Azacitidine and Venetoclax with or without Donor Lymphocyte Infusion in Relapsed AML Post Allo-HSCT: A Single-Institution Retrospective Study","publication_year":2024,"publication_date":"2024-11-05","ids":{"openalex":"https://openalex.org/W4405041504","doi":"https://doi.org/10.1182/blood-2024-193668"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2024-193668","doi":"https://doi.org/10.1182/blood-2024-193668","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood-2024-193668","pdf_url":"https://ashpublications.org/blood/article-pdf/144/Supplement 1/1481/2334820/blood-4228-main.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ashpublications.org/blood/article-pdf/144/Supplement 1/1481/2334820/blood-4228-main.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024051174","display_name":"Daniel T. Peters","orcid":"https://orcid.org/0000-0002-4655-0994","observed_orcids":["https://orcid.org/0000-0002-4655-0994"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel T Peters","raw_affiliation_strings":["1Division of Hematology, University of North Carolina School of Medicine, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Division of Hematology, University of North Carolina School of Medicine, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Coco Chang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Coco Chang","raw_affiliation_strings":["2Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038820409","display_name":"Anson E. Snow","orcid":"https://orcid.org/0000-0001-8645-9469","observed_orcids":["https://orcid.org/0000-0001-8645-9469"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anson Snow","raw_affiliation_strings":["2Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055282172","display_name":"Kaitlyn M Buhlinger","orcid":"https://orcid.org/0000-0003-1859-9763","observed_orcids":["https://orcid.org/0000-0003-1859-9763"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kaitlyn M. Buhlinger","raw_affiliation_strings":["2Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087130627","display_name":"Bianka A. Patel","orcid":"https://orcid.org/0000-0001-6536-0902","observed_orcids":["https://orcid.org/0000-0001-6536-0902"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bianka Patel","raw_affiliation_strings":["2Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054563814","display_name":"Taylor Dennison","orcid":"https://orcid.org/0000-0001-9582-2688","observed_orcids":["https://orcid.org/0000-0001-9582-2688"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Taylor Dennison","raw_affiliation_strings":["2Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Stephanie Dawson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I1333535994","display_name":"University of North Carolina Health Care","ror":"https://ror.org/00qz24g20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1333535994"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephanie Dawson","raw_affiliation_strings":["3Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I1333535994"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Sean Gallagher","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I1333535994","display_name":"University of North Carolina Health Care","ror":"https://ror.org/00qz24g20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1333535994"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sean Gallagher","raw_affiliation_strings":["3Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I1333535994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010652252","display_name":"Robyn Tolley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I1333535994","display_name":"University of North Carolina Health Care","ror":"https://ror.org/00qz24g20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1333535994"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robyn Tolley","raw_affiliation_strings":["3Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I1333535994"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Angela Nichols","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I1333535994","display_name":"University of North Carolina Health Care","ror":"https://ror.org/00qz24g20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1333535994"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Angela Nichols","raw_affiliation_strings":["3Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I1333535994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050087636","display_name":"Daniel R. Richardson","orcid":"https://orcid.org/0000-0001-9310-5773","observed_orcids":["https://orcid.org/0000-0001-9310-5773"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel R. Richardson","raw_affiliation_strings":["2Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025478600","display_name":"Anastasia Ivanova","orcid":"https://orcid.org/0000-0003-4321-2073","observed_orcids":["https://orcid.org/0000-0003-4321-2073"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anastasia Ivanova","raw_affiliation_strings":["2Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073215677","display_name":"Paul M. Armistead","orcid":"https://orcid.org/0000-0003-3983-5534","observed_orcids":["https://orcid.org/0000-0003-3983-5534"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul Armistead","raw_affiliation_strings":["2Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5040303721","display_name":"Joshua F. Zeidner","orcid":"https://orcid.org/0000-0002-9014-1514","observed_orcids":["https://orcid.org/0000-0002-9014-1514"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joshua F Zeidner","raw_affiliation_strings":["2Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5000,"currency":"USD","value_usd":5000},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"144","issue":"Supplement 1","first_page":"1481","last_page":"1481"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.004699999932199717,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/relapsed-acute-myeloid-leukemia","display_name":"relapsed acute myeloid leukemia","score":0.847000002861023},{"id":"https://openalex.org/keywords/azacitidine","display_name":"azacitidine","score":0.9660000205039978},{"id":"https://openalex.org/keywords/venetoclax","display_name":"venetoclax","score":1.0},{"id":"https://openalex.org/keywords/donor-lymphocyte-infusion","display_name":"donor lymphocyte infusion","score":0.9490000009536743},{"id":"https://openalex.org/keywords/allogeneic-hematopoietic-stem-cell-transplantation","display_name":"allogeneic hematopoietic stem cell transplantation","score":0.9470000267028809},{"id":"https://openalex.org/keywords/relapsed-refractory-aml","display_name":"relapsed/refractory AML","score":0.7730000019073486},{"id":"https://openalex.org/keywords/salvage-therapy","display_name":"salvage therapy","score":0.531000018119812},{"id":"https://openalex.org/keywords/complete-remission","display_name":"complete remission","score":0.7329999804496765},{"id":"https://openalex.org/keywords/event-free-survival","display_name":"event-free survival","score":0.8820000290870667},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8820000290870667},{"id":"https://openalex.org/keywords/donor-chimerism","display_name":"donor chimerism","score":0.8109999895095825},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.3089999854564667},{"id":"https://openalex.org/keywords/duration-of-response","display_name":"duration of response","score":0.4880000054836273}],"concepts":[{"id":"https://openalex.org/C2779675984","wikidata":"https://www.wikidata.org/wiki/Q23671272","display_name":"Venetoclax","level":4,"score":0.9532853364944458},{"id":"https://openalex.org/C2776239401","wikidata":"https://www.wikidata.org/wiki/Q416451","display_name":"Azacitidine","level":5,"score":0.8458471894264221},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6518632173538208},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.45928406715393066},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3609279990196228},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.35538724064826965},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3479663133621216},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3267607092857361},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.32357776165008545},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.1418425440788269},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2024-193668","doi":"https://doi.org/10.1182/blood-2024-193668","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood-2024-193668","pdf_url":"https://ashpublications.org/blood/article-pdf/144/Supplement 1/1481/2334820/blood-4228-main.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1182/blood-2024-193668","doi":"https://doi.org/10.1182/blood-2024-193668","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood-2024-193668","pdf_url":"https://ashpublications.org/blood/article-pdf/144/Supplement 1/1481/2334820/blood-4228-main.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.5400000214576721,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4405041504.pdf","grobid_xml":"https://content.openalex.org/works/W4405041504.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4362592484","https://openalex.org/W3048827006","https://openalex.org/W4310159665","https://openalex.org/W4362542584","https://openalex.org/W3131716652","https://openalex.org/W4401878169","https://openalex.org/W2899412336","https://openalex.org/W4401875674","https://openalex.org/W4401979026","https://openalex.org/W4401504076"],"abstract_inverted_index":{"Background:":[0],"Azacitidine":[1],"and":[2,18,45,136,150,226,257,304,323,358,365,371,418,427,453,504,539,688],"Venetoclax":[3],"(Aza/Ven)":[4],"is":[5,19,40,681],"a":[6,89,232,397,498,505,533],"standard":[7],"frontline":[8],"treatment":[9,118,162,164,297,310,591],"regimen":[10],"for":[11,22,34,97,194,431,592],"newly":[12],"diagnosed":[13,578],"older/unfit":[14],"AML":[15,54,83,99,113,196,646,658,694],"patients":[16],"(pts)":[17],"commonly":[20],"used":[21],"pts":[23,51,72,84,93,110,189,200,207,287,314,353,387,459,467,512,545,566,571,608,643],"with":[24,52,74,95,111,119,192,215,231,522,579,618,644,661],"relapsed/refractory":[25],"(R/R)":[26],"AML,":[27],"particularly":[28],"those":[29],"who":[30,546],"are":[31,64,640],"not":[32],"candidates":[33],"multi-agent":[35],"salvage":[36],"chemotherapy.":[37],"However,":[38],"there":[39],"limited":[41,664],"data":[42,680],"on":[43,142],"safety":[44],"clinical":[46,69,654],"activity":[47,122],"of":[48,71,92,160,172,179,199,248,277,296,309,313,333,335,343,352,385,439,476,501,508,552,559,604,626,656,690],"Aza/Ven":[49,75,96,161,193,290,336,421,496,614,627,674,691],"in":[50,81,349,462,483,520,544,563,567,610,642,671,692],"relapsed":[53,82,98,112,195,645,657,693],"post-allogeneic":[55],"hematopoietic":[56],"stem":[57],"cell":[58],"transplantation":[59],"(alloHSCT)":[60],"where":[61],"overall":[62,125,180,677],"outcomes":[63,70,655],"poor.":[65],"We":[66,87],"investigated":[67],"the":[68,157,246,292,432,474,479,523,568,685],"treated":[73,94,191,214,660],"+/-":[76],"donor":[77,273,481],"lymphocyte":[78],"infusions":[79],"(DLI)":[80],"post-alloHSCT.":[85,197,647,695],"Methods:":[86],"conducted":[88],"retrospective":[90,650],"analysis":[91,651],"post-alloHSCT":[100,249,659],"between":[101],"January":[102],"2015":[103],"to":[104,117,163,182,204,260,284,355,377,471,490,635,673,683],"June":[105],"2024.":[106],"Eligibility":[107],"criteria":[108],"included":[109,124],"(>5%":[114],"blasts)":[115],"prior":[116,470],"Aza/Ven.":[120,216,472,550,662],"Clinical":[121],"assessments":[123],"response":[126,173,181,379],"rates":[127,133,140,367],"(ORR:":[128],"CR+CRi+CRh+MLFS),":[129],"composite":[130],"complete":[131,137],"remission":[132,138],"(CRc:":[134],"CR+CRi+CRh),":[135],"(CR)":[139],"based":[141],"2022":[143],"ELN":[144],"criteria.":[145],"Event":[146],"Free":[147],"Survival":[148,152],"(EFS)":[149],"Overall":[151],"(OS)":[153],"were":[154,190,201,219,368,424,577],"calculated":[155],"from":[156,177,420,526,599],"first":[158,293],"date":[159],"failure,":[165],"relapse,":[166,478],"and/or":[167,345],"death":[168],"alone,":[169],"respectively.":[170,373],"Duration":[171],"(DOR)":[174],"was":[175,251,263,280,337,347,380,408,443,486,532,629],"measured":[176],"time":[178,247,259,276,308,376,475],"relapse":[183,250,262,279],"or":[184],"death.":[185],"Results:":[186],"Overall,":[187],"26":[188],"61.5%":[198],"female.":[202],"Prior":[203],"alloHSCT,":[205],"25/26":[206],"received":[208,289,315,460,468,547],"induction":[209],"therapy":[210],"versus":[211,299],"1":[212,399,402,423,585],"patient":[213,586],"Allograft":[217],"types":[218],"matched":[220,223],"unrelated":[221],"(n=12),":[222],"related":[224],"(n=7),":[225],"haploidentical":[227],"(n":[228,238,360],"=":[229,239],"7)":[230],"majority":[233],"receiving":[234,493,513,572,582],"reduced":[235],"intensity":[236],"conditioning":[237],"18;":[240],"69%).":[241],"The":[242,271,362,374,405,416],"median":[243,258,272,375,398,406,441,480,499,506],"age":[244],"at":[245,275],"62":[252],"years":[253],"(Range:":[254,266,282,339,401,411,488],"27-72":[255],"years)":[256],"post-HSCT":[261,278,298,477],"12.6":[264],"months":[265,410,426,445,448,451,455,503,598,623],"2.5":[267],"-":[268,403,413,528],"66.2":[269],"months).":[270],"chimerism":[274,482],"82.5%":[281],"47":[283],">95%).":[285,491],"Nineteen":[286],"(73%)":[288],"as":[291],"line":[294,438],"(1L)":[295],"2L":[300],"(n=3),":[301,303],"3L":[302],"4L":[305],"(n=1).":[306],"At":[307,473],"initiation,":[311],"96.2%":[312],"full":[316,324],"dose":[317,325],"azacitidine":[318],"(75mg/m2":[319],"x":[320,328],"7":[321,607],"days)":[322],"venetoclax":[326],"(100-400mg":[327],"28":[329],"days).":[330],"Median":[331],"number":[332],"cycles":[334],"3":[338],"1-27).":[340],"Dose":[341],"reduction":[342],"Aza":[344],"Ven":[346],"required":[348,587],"42.%":[350],"(n=11)":[351],"due":[354,634],"cytopenias":[356],"(n=6),":[357],"illness/frailty":[359],"=5).":[361],"ORR,":[363],"cCR":[364,540,612],"CR":[366,521,620],"69.2%,":[369],"57.7%,":[370],"38.5%,":[372],"best":[378],"1.9":[381],"months.":[382,510,530],"A":[383],"total":[384],"11":[386,597],"(42.3%)":[388],"achieved":[389],"MRD":[390],"negativity":[391],"by":[392,437],"flow":[393],"cytometry":[394],"(<0.01%)":[395],"after":[396,515,549,581,613,621,631],"cycle":[400,632],"4).":[404],"DOR":[407,524],"6.6":[409],"0.3":[412],"32.9":[414],").":[415],"medianEFS":[417],"OS":[419,442,500],"day":[422],"4.8":[425],"15.0":[428],"months,":[429],"respectively,":[430],"entire":[433],"cohort.":[434,569],"When":[435],"stratified":[436],"treatment,":[440],"17.4":[444],"(1L),":[446],"5.3":[447],"(2L),":[449],"4.4":[450],"(3L),":[452],"5.8":[454],"(4L).":[456],"Sixteen":[457],"(61.5%)":[458],"DLI":[461,469,494,514,548,669],"this":[463,484],"cohort;":[464],"10/16":[465],"(56.3%)":[466],"subgroup":[485],"76%":[487],"50":[489],"Pts":[492],"before":[495],"had":[497],"38.9":[502],"EFS":[507],"4.0":[509],"Of":[511,570],"Aza/Ven,":[516],"4/6":[517],"(66.7%)":[518],"remain":[519,609],"ranging":[525],"4.9":[527],"32.4":[529],"There":[531],"numerically":[534],"higher":[535],"ORR":[536],"(80%":[537],"vs.100%)":[538],"(60":[541],"vs":[542,555],"83.3)":[543],"Independent":[551],"DLI,":[553,574],"Graft":[554],"Host":[556],"Disease":[557],"(GVHD)":[558],"any":[560,573],"severity":[561],"developed":[562],"17":[564,633],"(65.4%)":[565],"4/16":[575],"(25%)":[576],"GVHD":[580,595],".":[583],"Only":[584],"systemic":[588],"(oral":[589],"steroids)":[590],"acute":[593],"skin":[594],"occurring":[596],"his":[600],"3rd":[601],"DLI.":[602],"As":[603],"July":[605],"2024,":[606],"ongoing":[611,619],"including":[615],"one":[616],"pt":[617,636],"33.6":[622],"(30":[624],"cycles)":[625],"(Ven":[628],"discontinued":[630],"preference).":[637],"Conclusions:":[638],"Outcomes":[639],"dismal":[641],"This":[648],"single-institution":[649],"reveals":[652],"favorable":[653],"These":[663],"findings":[665],"suggest":[666],"that":[667],"early":[668],"intervention":[670],"addition":[672],"may":[675],"improve":[676],"outcomes.":[678],"Further":[679],"warranted":[682],"investigate":[684],"optimal":[686],"sequence":[687],"duration":[689]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2025-10-10T00:00:00"}